Zacks Investment Research upgraded shares of National Health Investors (NYSE:NHI) from a sell rating to a hold rating in a research report report published on Tuesday.
According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “
A number of other equities research analysts have also recently commented on NHI. ValuEngine raised National Health Investors from a hold rating to a buy rating in a report on Tuesday, December 11th. KeyCorp set a $65.00 price objective on National Health Investors and gave the company a sell rating in a research report on Thursday, December 20th. Finally, Cantor Fitzgerald restated a hold rating and set a $80.00 price objective on shares of National Health Investors in a research report on Thursday, November 8th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and four have issued a buy rating to the company. The stock currently has an average rating of Hold and a consensus target price of $75.38.
The company also recently disclosed a quarterly dividend, which was paid on Thursday, January 31st. Stockholders of record on Monday, December 31st were given a dividend of $1.00 per share. The ex-dividend date of this dividend was Friday, December 28th. This represents a $4.00 dividend on an annualized basis and a dividend yield of 4.87%. National Health Investors’s payout ratio is 75.05%.
In other news, CIO Kevin Carlton Pascoe sold 2,070 shares of the firm’s stock in a transaction dated Friday, December 14th. The stock was sold at an average price of $79.60, for a total transaction of $164,772.00. Following the completion of the transaction, the executive now owns 25,123 shares in the company, valued at $1,999,790.80. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Kristin Sallee Gaines sold 10,708 shares of the firm’s stock in a transaction dated Thursday, December 13th. The shares were sold at an average price of $80.36, for a total value of $860,494.88. Following the transaction, the insider now owns 43,644 shares of the company’s stock, valued at approximately $3,507,231.84. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 14,028 shares of company stock valued at $1,119,529. Company insiders own 5.63% of the company’s stock.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Vanguard Group Inc. grew its position in National Health Investors by 1.2% in the third quarter. Vanguard Group Inc. now owns 6,382,904 shares of the real estate investment trust’s stock worth $482,484,000 after acquiring an additional 76,209 shares in the last quarter. Vanguard Group Inc grew its position in National Health Investors by 1.2% in the third quarter. Vanguard Group Inc now owns 6,382,904 shares of the real estate investment trust’s stock worth $482,484,000 after acquiring an additional 76,209 shares in the last quarter. BlackRock Inc. grew its position in National Health Investors by 1.7% in the fourth quarter. BlackRock Inc. now owns 4,216,426 shares of the real estate investment trust’s stock worth $318,508,000 after acquiring an additional 71,399 shares in the last quarter. Dimensional Fund Advisors LP grew its position in National Health Investors by 1.0% in the third quarter. Dimensional Fund Advisors LP now owns 645,077 shares of the real estate investment trust’s stock worth $48,759,000 after acquiring an additional 6,456 shares in the last quarter. Finally, Renaissance Technologies LLC grew its position in National Health Investors by 32.5% in the third quarter. Renaissance Technologies LLC now owns 636,240 shares of the real estate investment trust’s stock worth $48,093,000 after acquiring an additional 155,940 shares in the last quarter. Institutional investors own 69.65% of the company’s stock.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
See Also: Depreciation
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.